In the rush to develop a viable vaccine to protect against COVID-19, what should patients expect in terms of timing, efficacy, and safety? George M. Abraham, MD, MPH, FACP, FIDSA, Chair of the Infectious Disease Board for the American Board of Internal Medicine, shares his thoughts on the current state of research and clinical trials, timelines, availability, and when things might return to normal.